Rein Therapeutics, Inc. Restructuring Reserve, Current
Rein Therapeutics, Inc. (RNTX) had Restructuring Reserve, Current of $12.00 thousand as of 2023-09-30, per its 10-Q filed 2023-10-13.
Discontinued › Notes
us-gaap:RestructuringReserveCurrent · last filed 2023-10-13
- 2023-09-30: Restructuring Reserve, Current $12.00K.
- 2023-06-30: Restructuring Reserve, Current $35.00K.
- 2023-03-31: Restructuring Reserve, Current $992.00K.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2023-09-30 | $12.00K 10-Q · filed 2023-10-13 |
| 2023-06-30 | $35.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $992.00K 10-Q · filed 2023-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |